Sign inJoin waitlistJoin the waitlist

WK

Wade Kyono

. . . . . Assistant Professor of Pediatrics, University of Hawaii John A. Burns School of Medicine. · University of Hawaii Board of Regents

Credentials: · ·

History

University of Hawaii Board of Regents
Present

Pediatrics
1991–1994
Univ of Hawaii John A Burns Sch of Med
1987–1991

Research

First pediatric experience of SL-401, a CD123-targeted therapy, in patients with blastic plasmacytoid dendritic cell neoplasm: report of three cases
Case report · Journal of Hematology & Oncology · 2018 · 44 citations
Symptom Screening Linked to Care Pathways for Pediatric Patients With Cancer: A Randomized Clinical Trial
JAMA · 2024 · 33 citations
CBL-GRB2 interaction in myeloid immunoreceptor tyrosine activation motif signaling
The Journal of Immunology · 1998 · 31 citations

MB
Melissa Beauchemin
8 papers
Michael Roth
8 papers
Allison Grimes
7 papers
Catherine Aftandilian
7 papers
David Freyer
7 papers
Allison King
6 papers
Etan Orgel
6 papers
Farha Sherani
6 papers
Kara Kelly
6 papers
Lolie Yu
6 papers
Ramamoorthy Nagasubramanian
6 papers
Scott Bradfield
6 papers

Grants

Rcmi Clinical Research Infrastructure Initiative (Rcrii)
National Center for Research Resources · P20
Project lead · $104.9K · University of Hawaii at Manoa
2004–2006
Pacific Research Center for Early Human Development
National Center for Research Resources · U54
Project lead · $1.8M · University of Hawaii at Manoa
1999–2005

Clinical trials

Testing an Enhanced Digital Delivery Model for Inherited Cancer Genetic Testing in Young Adults With Cancer
Site PI · Recruiting
Alliance for Clinical Trials in Oncology
2025–2029
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
Site PI · Recruiting · Phase 2
National Cancer Institute (NCI)
2025–2028
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
Site PI · Recruiting · Phase 2
National Cancer Institute (NCI)
2025–2030
A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)
Site PI · Recruiting · Phase 3
Children's Oncology Group
2025–2031